The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Metabolic Syndrome and Dementia Risk in a Multiethnic Elderly Cohort
Open accessAbstract
BACKGROUND/AIMS: The metabolic syndrome (MeSy) may be related to Alzheimer's disease (AD). Our aims were to investigate the association of the MeSy with incident dementia in a multiethnic elderly cohort in the United States. METHODS: We conducted cross-sectional and prospective analyses in 2,476 men and women aged 65 years and older and with data available on the MeSy and dementia diagnosis in Northern New York City. MeSy was defined by the National Cholesterol Education Program Adult Treatment Program III and the European Group for the Study of Insulin Resistance criteria. Dementia was diagnosed using standard criteria. RESULTS: No association was found between MeSy and prevalent dementia. After 4.4 years of follow-up, 236 individuals of the 1,833 without prevalent dementia developed dementia. MeSy was not associated with incident dementia. Of the components of the MeSy, diabetes and hyperinsulinemia were associated with an increased risk of incident AD [hazard ratio 1.4 (95% CI 1.0-2.1), and hazard ratio 1.4 (95% CI 0.9-2.7), respectively] and dementia associated with stroke [hazard ratio 1.9 (95% CI 1.1-3.1), and hazard ratio 2.3 (95% CI 1.1-4.7), respectively]. CONCLUSIONS: The MeSy was not associated with an increased dementia risk in a multiethnic elderly cohort, but diabetes and hyperinsulinemia were. In the elderly, examining diabetes and hyperinsulinemia separately may be preferable to using the MeSy as a risk factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We found that two definitions of the metabolic syndrome, one that included diabetes and one that included hyperinsulinemia, were not related to Alzheimer’s disease risk (Muller et al., 2007).”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Muller et al., 2007
In the citing paper
“However, the individual components of hyperinsulinemia and diabetes as defined within the metabolic syndrome definition were associated with a higher risk of Alzheimer’s disease.”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Muller et al., 2007
In the citing paper
“Of the components of the metabolic syndrome, diabetes and hyperinsulinemia were associated with an increased incident Alzheimer’s disease (hazard ratio; 95%CI respectively 1.4; 1.0–2.1 and 1.4; 0.9–2.7) and vascular dementia risk(hazard ratio; 95%CI respectively 1.9; 1.1–3.1 and 2.3; 1.1–4.7).”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Muller et al., 2007
In the citing paper
“Of the components of the metabolic syndrome, diabetes and hyperinsulinemia were associated with an increased incident Alzheimer’s disease (hazard ratio; 95%CI respectively 1.4; 1.0–2.1 and 1.4; 0.9–2.7) and vascular dementia risk(hazard ratio; 95%CI respectively 1.9; 1.1–3.1 and 2.3; 1.1–4.7).”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Muller et al., 2007
In the citing paper
“Of the components of the metabolic syndrome, diabetes and hyperinsulinemia were associated with an increased incident Alzheimer’s disease (hazard ratio; 95%CI respectively 1.4; 1.0–2.1 and 1.4; 0.9–2.7) and vascular dementia risk(hazard ratio; 95%CI respectively 1.9; 1.1–3.1 and 2.3; 1.1–4.7).”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Muller et al., 2007
In the citing paper
“metabolic syndrome was not associated with incident dementia.”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Muller et al., 2007
In the citing paper
“Of the components of the metabolic syndrome, diabetes and hyperinsulinemia were associated with an increased incident Alzheimer’s disease (hazard ratio; 95%CI respectively 1.4; 1.0–2.1 and 1.4; 0.9–2.7) and vascular dementia risk(hazard ratio; 95%CI respectively 1.9; 1.1–3.1 and 2.3; 1.1–4.7).”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Muller et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Cited by
Sorted by citations
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Cheng, G., Huang, C., Deng, H., & Wang, H. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02758.x · Cited by 1,040
Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563
Janssen, C. I. F., & Kiliaan, A. J. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.002 · Cited by 528
Impact of Metabolic Syndrome on Cognition and Brain: A Selected Review of the Literature
Yates, K. F., Sweat, V., Yau, P. L., Turchiano, M. M., & Convit, A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.252759 · Cited by 444
Systematic review of dementia prevalence and incidence in United States race/ethnic populations
Mehta, K. M., & Yeo, G. W. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.2360 · Cited by 439
Defining the relationship between hypertension, cognitive decline, and dementia: a review
Walker, K. A., Power, M. C., & Gottesman, R. F. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0724-3 · Cited by 394
An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease
Zhang, J., Chen, C., Hua, S., Liao, H., Wang, M., Xiong, Y., & Cao, F. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.024 · Cited by 376
Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease
Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C. A., Santamato, A., Sancarlo, D., Vendemiale, G., Pilotto, A., & Panza, F. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.007 · Cited by 365
Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia
Raffaitin, C., Gin, H., Empana, J. P., Helmer, C., Berr, C., Tzourio, C., Portet, F., Dartigues, J., Alpérovitch, A., & Barberger‐Gateau, P. (2008) · Diabetes Care · doi:10.2337/dc08-0272 · Cited by 338
Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives
Ma, L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00009 · Cited by 323
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
Li, X., Leng, S. X., & Song, D. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s74042 · Cited by 314
Juster, R.-P., Bizik, G., Picard, M., Arsenault-Lapierre, G., Sindi, S., Trepanier, L., Marin, M.-F., Wan, N., Sekerovic, Z., Lord, C., et al. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000289 · Cited by 268
Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia
Ng, T. P., Feng, L., Nyunt, M. S. Z., Feng, L., Gao, Q., Lim, M. L., Collinson, S. L., Chong, M. S., Lim, W. S., Lee, T.-S. W., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4899 · Cited by 253
Buch, A., Carmeli, E., Boker, L. K., Marcus, Y., Shefer, G., Kis, O., Berner, Y., & Stern, N. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.008 · Cited by 227
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging
Solfrizzi, V., Scafato, E., Frisardi, V., Seripa, D., Logroscino, G., Maggi, S., Imbimbo, B. P., Galluzzo, L., Baldereschi, M., Gandin, C., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.223 · Cited by 227
The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women
Yaffe, K., Weston, A. L., Blackwell, T., & Krueger, K. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.566 · Cited by 220
Power, M. C., Weuve, J., Gagne, J. J., McQueen, M. B., Viswanathan, A., & Blacker, D. (2011) · Epidemiology · doi:10.1097/ede.0b013e31822708b5 · Cited by 213
Adiposity, Type 2 Diabetes, and Alzheimer's Disease
Luchsinger, J. A., & Gustafson, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1022 · Cited by 221
Self-citationCognitive decline, dietary factors and gut–brain interactions
Caracciolo, B., Xu, W., Collins, S. M., & Fratiglioni, L. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.011 · Cited by 213
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease
Luchsinger, J. A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.048 · Cited by 171
Self-citationCognitive impairment and depression: Meta-analysis of structural magnetic resonance imaging studies
Žáčková, L., Jáni, M., Brázdil, M., Nikolova, Y. S., & Marečková, K. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102830 · Cited by 182
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms
Panza, F., Frisardi, V., Capurso, C. A., Imbimbo, B. P., Vendemiale, G., Santamato, A., D’Onofrio, G., Seripa, D., Sancarlo, D., Pilotto, A., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091669 · Cited by 166
Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
Sambra, V., Echeverría, F., Valenzuela, A., Chouinard‐Watkins, R., & Valenzuela, R. (2021) · Nutrients · doi:10.3390/nu13030986 · Cited by 166
Tang, X., Zhao, W., Lu, M., Zhang, X., Zhang, P., Xin, Z., Sun, R., Tian, W., Cardoso, M. A., Yang, J., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.028 · Cited by 154
Gao, Y., Changquan, H., Zhao, K., Ma, L., Qiu, X., Zhang, L., Xiu, Y., Chen, L., Lü, W., Huang, C., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3845 · Cited by 165
RetractedMetabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies
Atti, A. R., Valente, S., Iodice, A., Caramella, I., Ferrari, B., Albert, U., Mandelli, L., & Ronchi, D. D. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.01.214 · Cited by 157
Midlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies
Tolppanen, A., Solomon, A., Soininen, H. S., & Kivipelto, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120802 · Cited by 143
Epidemiological of and risk factors for Alzheimer's disease: A review
Povová, J., Ambrož, P., Bar, M., Pavuková, V., Šerý, O., Tomášková, H., & Janout, V. (2012) · Biomedical Papers · doi:10.5507/bp.2012.055 · Cited by 143
Vega, I. E., Cabrera, L. Y., Wygant, C. M., Ortiz, D. V., & Counts, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161261 · Cited by 143
Solfrizzi, V., Scafato, E., Capurso, C. A., D’Introno, A., Colacicco, A. M., Frisardi, V., Vendemiale, G., Baldereschi, M., Crepaldi, G., Carlo, A. D., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.012 · Cited by 131
Siervo, M., Harrison, S. L., Jagger, C., Robinson, L. A., & Stephan, B. C. M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132279 · Cited by 134
Schilling, S., Tzourio, C., Soumaré, A., Kaffashian, S., Dartigues, J., Ancelin, M., Samieri, C., Dufouil, C., & Debette, S. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002265 · Cited by 121
Association between metabolic syndrome and risk of incident dementia in UK Biobank
Qureshi, D., Collister, J. A., Allen, N. E., Kuźma, E., & Littlejohns, T. J. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13439 · Cited by 116
Metabolic Syndrome and Risk of Dementia in Older Adults
Forti, P., Pisacane, N., Rietti, E., Lucicesare, A., Olivelli, V., Mariani, E., Mecocci, P., & Ravaglia, G. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02731.x · Cited by 112
Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease
Carlsson, C. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100012 · Cited by 109
Beydoun, M. A., Lhotsky, A., Wang, Y., Forno, G. D., An, Y., Metter, E. J., Ferrucci, L., O’Brien, R., & Zonderman, A. B. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn229 · Cited by 111
Qiu, C., Xu, W., & Fratiglioni, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091663 · Cited by 107
van den Berg, E., Dekker, J. M., Nijpels, G., Kessels, R. P. C., Kappelle, L. J., de Haan, E. H. F., Heine, R. J., Stehouwer, C. D. A., & Biessels, G. J. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000160959 · Cited by 102
METABOLIC SYNDROME IN THE ELDERLY: AN OVERVIEW OF THE EVIDENCE
Denys, K., Cankurtaran, M., Janssens, W. H., & Petrovic, M. (2009) · Acta Clinica Belgica · doi:10.1179/acb.2009.006 · Cited by 108
Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome
Borshchev, Y. Y., Uspensky, Y. P., & Galagudza, M. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116932 · Cited by 97
Patel, C., Georrge, J. J., Modi, K., Narechania, M. B., Patel, D. P., Gonzalez, F. J., & Pandya, H. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1404931 · Cited by 86
Diabetes, related conditions, and dementia
Luchsinger, J. A. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.063 · Cited by 88
Self-citationShared genetic etiology underlying Alzheimer’s disease and type 2 diabetes
Hao, K., Di Narzo, A. F., Ho, L., Luo, W., Li, S., Chen, R., Li, T., Dubner, L., & Pasinetti, G. M. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.06.006 · Cited by 84
“For example, one of the major long-term complications of T2D is an increased risk for developing Alzheimer’s disease (AD) (Luchsinger and Gustafson, 2009; Muller et al., 2007; Vagelatos and Eslick, 2013).”
BackgroundIs Insulin Resistant Brain State a Central Feature of the Metabolic-Cognitive Syndrome?
Frisardi, V., Solfrizzi, V., Capurso, C. A., Imbimbo, B. P., Vendemiale, G., Seripa, D., Pilotto, A., & Panza, F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100015 · Cited by 85
Metabolic Syndrome Over 10 Years and Cognitive Functioning in Late Midlife
Akbaraly, T. N., Mika Kivimaki, B., Shipley, M. J., Tabák, Á. G., Jokela, M. M., Virtanen, M., Marmot, M. G., Ferrie, J. E., & Singh‐Manoux, A. (2009) · Diabetes Care · doi:10.2337/dc09-1218 · Cited by 80
Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Panza, F., Frisardi, V., Seripa, D., Imbimbo, B. P., Sancarlo, D., D’Onofrio, G., Addante, F., Paris, F., Pilotto, A., & Solfrizzi, V. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391818 · Cited by 84
A Review of the Major Vascular Risk Factors Related to Alzheimer's Disease
Polidori, M. C., Pientka, L., & Mecocci, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120871 · Cited by 80
Vascular cognitive impairment – Past, present, and future challenges
Badji, A., Youwakim, J., Cooper, A., Westman, E., & Marseglia, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102042 · Cited by 84
Metabolic Syndrome, Cognitive Performance, and Dementia
Crichton, G. E., Elias, M. F., Buckley, J. D., Murphy, K. J., Bryan, J., & Frisardi, V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111022 · Cited by 76
Metabolic Syndrome and Cognitive Decline in Early Alzheimer's Disease and Healthy Older Adults
Watts, A. S., Loskutova, N., Burns, J. M., & Johnson, D. K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121168 · Cited by 72
Elevated HbA 1c is Associated with Increased Risk of Incident Dementia in Primary Care Patients
Ramírez, A., Wolfsgruber, S., Lange, C., Kaduszkiewicz, H., Weyerer, S. B., Werle, J., Pentzek, M., Fuchs, Â., Riedel-Heller, S. G., Luck, T., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141521 · Cited by 74
Janssen, C., Jansen, D., Mutsaers, M. P. C., Dederen, P. J., Geenen, B., Mulder, M., & Kiliaan, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155307 · Cited by 71
Kim, Y. J., Kim, S. M., Jeong, D. H., Lee, S., Ahn, M., & Ryu, O. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00620-5 · Cited by 67
Guan, J., Huang, C.-Q., Li, Y., Wan, C., You, C., Wang, Z., Liu, Y., & Liu, Q. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111160 · Cited by 69
Reassessment of Pioglitazone for Alzheimer’s Disease
Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 71
Changes in Metabolic Syndrome Status and Risk of Dementia
Lee, J. E., Shin, D. W., Han, K., Kim, D., Yoo, J. E., Lee, J., Kim, S., Son, K. Y., Cho, B., & Kim, M. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010122 · Cited by 63
Zuin, M., Roncon, L., Passaro, A., Cervellati, C., & Zuliani, G. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.020 · Cited by 63
Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
Ramos‐Rodríguez, J. J., Ortiz-Barajas, O., Gamero-Carrasco, C., de la Rosa, P. R., Infante‐Garcia, C., Zopeque-Garcia, N., Lechuga-Sancho, A. M., & Garcı́a-Alloza, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.005 · Cited by 61
Feng, L., Chong, M. S., Lim, W. S., Lee, T.-S. W., Collinson, S. L., Yap, P. L. K., & Ng, T. P. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121885 · Cited by 58
Insulin resistance, diabetes and cognitive function: Consequences for preventative strategies
Bourdel‐Marchasson, I., Lapre, É., Laksir, H., & Puget, E. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.03.001 · Cited by 57
Childhood and adolescent obesity and long‐term cognitive consequences during aging
Wang, J., Freire, D., Knable, L. A., Zhao, W., Gong, B., Mazzola, P., Ho, L., Levine, S., & Pasinetti, G. M. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23708 · Cited by 55
Tournoy, J., Lee, D. M., Pendleton, N., O’Neill, T. W., O'Connor, D. B., Bártfai, G., Casanueva, F. F., Finn, J. D., Forti, G., Giwercman, A., et al. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1144 · Cited by 53
Current Epidemiological Approaches to the Metabolic-Cognitive Syndrome
Panza, F., Solfrizzi, V., Logroscino, G., Maggi, S., Santamato, A., Seripa, D., & Pilotto, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111496 · Cited by 52
Katsumata, Y., Todoriki, H., Higashiuesato, Y., Yasura, S., Willcox, D. C., Ohya, Y., Willcox, B. J., & Dodge, H. H. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr189 · Cited by 51
Wang, J., Tang, C. Y., Ferruzzi, M. G., Gong, B., Song, B. J., Janle, E. M., Chen, T., Cooper, B. R., Varghese, M., Cheng, A., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300230 · Cited by 47
The Metabolic Syndrome and Cognitive Performance: The Northern Manhattan Study
Vieira, J. R., Elkind, M. S. V., Moon, Y. P., Rundek, T., Boden-Albala, B. M., Paik, M. C., Sacco, R. L., & Wright, C. B. (2011) · Neuroepidemiology · doi:10.1159/000332208 · Cited by 46
Liu, C., Lin, M.-H., Peng, L., Chen, L., Su, C.-T., Liu, L.-K., & Chen, L. Y. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0010-2 · Cited by 48
Modeling Metabolic Syndrome and Its Association with Cognition: The Northern Manhattan Study
Levin, B., Llabre, M., Dong, C., Elkind, M., Stern, Y., Rundek, T., Sacco, R., & Wright, C. (2014) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617714000861 · Cited by 45
Peters, R. K. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2153 · Cited by 45
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer’s disease
Lin, C., Frigerio, I., Boon, B. D. C., Zhou, Z., Rozemüller, A. J. M., Bouwman, F. H., Schoonheim, M. M., van de Berg, W. D. J., & Jonkman, L. E. (2022) · Brain · doi:10.1093/brain/awac093 · Cited by 45
Machado‐Fragua, M. D., Fayossé, A., Yerramalla, M. S., van Sloten, T. T., Tabák, Á. G., Mika Kivimaki, B., Sabia, S., & Singh‐Manoux, A. (2022) · Diabetes Care · doi:10.2337/dc22-0206 · Cited by 44
Luo, L., Yang, M. J., Hao, Q., Yue, J., & Dong, B. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.10.001 · Cited by 44
Ramos‐Rodríguez, J. J., Infante‐Garcia, C., Galindo-Gonzalez, L., Garcia-Molina, Y., Lechuga-Sancho, A. M., & Garcı́a-Alloza, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9311-2 · Cited by 43
Bokura, H., Nagai, A., Oguro, H., Kobayashi, S., & Yamaguchi, S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000322057 · Cited by 42
Metabolic Syndrome, Diabetes, Poor Cognition, and Dementia in the Caerphilly Prospective Study
Creavin, S., Gallacher, J., Bayer, A. J., Fish, M., Ebrahim, S. B. J., & Ben‐Shlomo, Y. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111550 · Cited by 39
Metabolic Syndrome: Is It Time to Add the Central Nervous System?
Rojas, M., Chávez-Castillo, M., Pírela, D., Parra, H., Nava, M., Chacín, M., Angarita, L., Áñez, R., Salazar, J. J., Ortíz, R., et al. (2021) · Nutrients · doi:10.3390/nu13072254 · Cited by 40
Zhang, X., Geng, T., Li, N., Wu, L., Wang, Y., Zheng, D., Guo, B., & Wang, B. (2022) · Nutrients · doi:10.3390/nu15010069 · Cited by 35
Metabolic Syndrome and Cognition in Patients with Manifest Atherosclerotic Disease: The SMART Study
Muller, M., van Raamt, F., Visseren, F. L. J., Kalmijn, S., Geerlings, M. I., Mali, W. P. T. M., & van der Graaf, Y. (2009) · Neuroepidemiology · doi:10.1159/000264825 · Cited by 33
Self-citationHao, Z., Wu, B., Wang, D., & Liu, M. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00527.x · Cited by 33
Dearborn, J. L., Knopman, D., Sharrett, A. R., Schneider, A. L. C., Jack Jr., C. R., Coker, L. H., Alonso, A., Selvin, E., Mosley, T. H., Wagenknecht, L. E., et al. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000362265 · Cited by 32
Blood pressure and Alzheimer's disease: A review of meta-analysis
Saiz-Vázquez, O., Puente-Martínez, A., Pacheco, J., & Landa, S. U. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1065335 · Cited by 32
Glycemic load and risk of Alzheimer's disease.
Luchsinger, J. A., Tang, M. ‐., & Mayeux, R. P. (2007) · PubMed · Cited by 29
Self-citationOoi, C. P., Loke, S. C., Yassin, Z., & Hamid, T.-A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007220.pub2 · Cited by 29
Slachevsky, A., Pedro Zitko, M., Martínez‐Pernía, D., Forno, G., Court, F. A., Lillo, P., Villagra, R., Duran-Aniotz, C. A., Parrao, T., Assar, R., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01866-4 · Cited by 27
Risk of mild cognitive impairment among older adults in the United States by ethnoracial group
Perales‐Puchalt, J., Gauthreaux, K. M., Shaw, A. R., McGee, J. L., Teylan, M., Chan, K. C. G., Rascovsky, K., Kukull, W. A., & Vidoni, E. D. (2020) · International Psychogeriatrics · doi:10.1017/s1041610219002175 · Cited by 25
Association of mild cognitive impairment and metabolic syndrome in patients with hypertension
Mehra, A., Suri, V., Kumari, S., Avasthi, A., & Grover, S. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102185 · Cited by 25
Diabetes, Insulin and Alzheimer's Disease
Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24
Cognitive disorders in diabetic patients
Koekkoek, P. S., Rutten, G. E. H. M., & Biessels, G. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00011-4 · Cited by 27
Li, P., Quan, W., Lü, D., Wang, Y., Zhang, H., Liu, S., Jiang, R., & Zhou, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167327 · Cited by 23
Dahl, A. (2009) · University Library of Skövde (University of Skövde) · Cited by 23
Overman, M. J., Pendleton, N., O’Neill, T. W., Bártfai, G., Casanueva, F. F., Forti, G., Rastrelli, G., Giwercman, A., Han, T. S., Huhtaniemi, I. T., et al. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.02.004 · Cited by 22
Moulignier, A., & Costagliola, D. G. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_123 · Cited by 23
Kinno, R., Mori, Y., Kubota, S., Nomoto, S., Futamura, A., Shiromaru, A., Kuroda, T., Yano, S., Ishigaki, S., Murakami, H., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101746 · Cited by 21
Phrommintikul, A., Sa‐nguanmoo, P., Sripetchwandee, J., Vathesatogkit, P., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-23550-9 · Cited by 21
Metabolic Syndrome and Cognition: Follow-Up Study of Chinese Over-55-Year-Olds
Przybycien-Gaweda, P. M., Gwee, X., Gao, Q., Chua, D. Q. L., Fam, J., & Ng, T. P. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000509124 · Cited by 20
Viscogliosi, G., Chiriac, I. M., Andreozzi, P., & Ettorre, E. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.09.001 · Cited by 20
Qiu, S.-D., Zhang, D. L., Ma, L., Li, Q., Wang, L.-Y., Wang, Y.-D., Wang, Y.-C., Xiong, S.-Y., & Tan, L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251326553 · Cited by 23
Viscogliosi, G., Chiriac, I. M., Andreozzi, P., & Ettorre, E. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12296 · Cited by 19
Wang, X., Luan, D., Xin, S., Liu, Y., & Gao, Q. (2019) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317519865428 · Cited by 20
Metadata
- Authors
- Muller, M., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A.
- Affiliations
- University Medical Center Utrecht (NL)
- Columbia University (US)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 24
- Issue
- 3
- Pages
- 185-192
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- PMC
- PMC2268640
- OpenAlex
- W2134834226
- Cited by
- 175
- References
- 43
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 15 · 2020: 11 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 8 · 2014: 15 · 2013: 13 · 2012: 14
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- PubMed Central (acceptedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Internationale Stichting Alzheimer Onderzoek
- National Institute on Aging (P01AG007232, K08AG20856-01, K08AG020856, AG 07702, AG 07232, P0L-AG07232)
- National Center for Research Resources (RR006451)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- metabolic syndrome, dementia risk, Alzheimer's disease, incident dementia, diabetes mellitus, hyperinsulinemia, stroke, older adults, multi-ethnic cohort, insulin resistance
- MeSH terms
- Aged, Blood Pressure, Cholesterol, Dementia, Diabetes Mellitus, Ethnicity, Female, Humans, Insulin, Longitudinal Studies, Male, Middle Aged, New York City, Risk, Triglycerides, Cohort Studies, Metabolic Syndrome, Waist-Hip Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
